Ketamine and neuroticism: a double-hit hypothesis of internalizing disorders

Personality Neuroscience
N McNaughton, Paul Glue

Abstract

Psychiatric disorders can often be viewed as extremes of personality traits. The primary action of drugs that ameliorate these disorders may, thus, be to alter the patient's position on a relevant trait dimension. Here, we suggest that interactions between such trait dimensions may also be important for disorder. Internalizing disorders show important differences in terms of range of activity and speed of response of medications. Established antidepressant and anxiolytic medications are slow in onset and have differing effects across different internalizing disorders. In contrast, low-dose ketamine is rapidly effective and improves symptom ratings in all internalizing disorders. To account for this, we propose a "double hit" model for internalizing disorders: generation (and maintenance) require two distinct forms of neural dysfunction to coincide. One hit, sensitive to ketamine, is disorder-general: dysfunction of a neural system linked to high levels of the personality trait of neuroticism. The other hit is disorder-specific: dysfunction of one of a set of disorder-specific neural modules, each with its own particular pattern of sensitivity to conventional drugs. Our hypothesis applies only to internalizing disorders. So, we ...Continue Reading

References

Jan 1, 1992·Annual Review of Psychology·D C Fowles
Aug 1, 1991·Journal of Abnormal Psychology·L A Clark, D Watson
Jul 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·G AndrewsS Henderson
Feb 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·A C McFarlane
Mar 13, 1998·Annual Review of Psychology·S MinekaL A Clark
Nov 3, 1998·QJM : Monthly Journal of the Association of Physicians·I H MillsR J Merriman
Jan 8, 1999·Journal of Affective Disorders·H HechtD von Zerssen
Oct 16, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H G Westenberg
Oct 18, 2000·European Journal of Pharmacology·C C Gispen-de Wied
Oct 24, 2002·Journal of Psychiatric Research·Ronald C Albucher, Israel Liberzon
Aug 16, 2003·Journal of Clinical Psychopharmacology·Murad AtmacaMurat Kuloglu
Jun 23, 2004·Journal of Clinical Psychopharmacology·Atul C PandeJohn L Werth
Jul 1, 2004·Neuroscience and Biobehavioral Reviews·Neil McNaughton, Philip J Corr
Apr 6, 2006·The American Psychologist·Dan P McAdams, Jennifer L Pals
Aug 9, 2006·Archives of General Psychiatry·Carlos A ZarateHusseini K Manji
Dec 6, 2006·Journal of Personality and Social Psychology·Colin G DeYoung
Apr 1, 2007·Neuropsychiatric Disease and Treatment·Jeffrey R Strawn, Thomas D Geracioti
May 20, 2009·The American Psychologist·Benjamin B Lahey
Nov 12, 2009·Psychological Medicine·J W GriffithJ M Sutton
Nov 17, 2009·Journal of Clinical Psychopharmacology·Lakshmi N RavindranMurray B Stein
Apr 27, 2010·The Journal of Pain : Official Journal of the American Pain Society·Winfried HäuserClaudia Sommer
May 4, 2010·Psychological Science·Colin G DeYoungJeremy R Gray
Jul 30, 2010·The Journal of Clinical Psychiatry·Lakshmi N Ravindran, Murray B Stein
Aug 10, 2010·Anesthesiology·Edward F Domino
Mar 4, 2011·International Clinical Psychopharmacology·Douglas E FeltnerRobert Bielski
Apr 13, 2011·Biological Psychiatry·Paul GlueStephen Duffull
Jul 13, 2012·The Cochrane Database of Systematic Reviews·Harm van MarwijkIngrid I Riphagen
Oct 17, 2012·Neuroscience and Biobehavioral Reviews·Johan OrmelAndré Aleman
Nov 7, 2012·Journal of Personality·Colin G DeYoungJordan B Peterson
May 21, 2013·Neuroscience and Biobehavioral Reviews·Michelle N ServaasAndré Aleman
Jun 21, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carolyn I RodriguezHelen B Simpson
Oct 16, 2016·Development and Psychopathology·Neil McNaughton, Philip J Corr
Mar 24, 2017·Journal of Abnormal Psychology·Roman KotovMark Zimmerman
Apr 8, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Alexander McGirrRaymond W Lam
May 13, 2017·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Thomas A Widiger, Joshua R Oltmanns
Jan 21, 2018·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Roman KotovDavid Watson

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
Cristiano Tschiedel Belem da SilvaGisele Gus Manfro
© 2022 Meta ULC. All rights reserved